Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lifecore Biomedical, Inc. - Common Stock (NQ:LFCR)

7.829 +0.059 (+0.75%)
Streaming Delayed Price Updated: 10:15 AM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lifecore Biomedical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Lifecore Biomedical Announces Sale of Curation Foods’ O Olive Oil and Vinegar® Business
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Analyst Ratings for Lifecore Biomedical ↗
 
Via Benzinga
News headline image
Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Lifecore Biomedical, Inc. - Common Stock's Return On Capital Employed Insights ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 20, 2023 ↗
 
Via Benzinga
News headline image
Crude Oil Down 2%; Enzo Biochem Shares Spike Higher ↗
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 300 points on Friday. The Dow traded down 1.07% to 31,899.93 while the NASDAQ fell 0.68% to 11,638.13. The S&P... 
Via Benzinga
News headline image
US Stocks Tumble; Dow Drops Over 400 Points ↗
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 400 points on Friday. The Dow traded down 1.30% to 31,825.91 while the NASDAQ fell 0.97% to 11,603.08. The S&P 500, also... 
Via Benzinga
News headline image
Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Enzo Biochem, Inc. (NYSE: ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp. 
Via Benzinga
News headline image
Lifecore Biomedical Signs Term Sheet with Existing Long-Term Customer to Expand CDMO Relationship
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Announces Intent to Explore Strategic Alternatives
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Reports Second Quarter Fiscal Year 2023 Results
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Announces Sale of Curation Foods’ Avocado Products Business
Proceeds to be used for debt paydown 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Around $10M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying ↗
Although US stocks closed lower on Wednesday, there were a few notable insider trades. 
Via Benzinga
News headline image
Lifecore Biomedical Receives Notice from Nasdaq Regarding Delayed Quarterly Report
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Raises Capital with Private Placement of Convertible Preferred Stock; Amends Credit Facilities
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
4 Cheapest Defensive Stocks You Should Think About ↗
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 63 companies set new 52-week lows. 
Via Benzinga
News headline image
$5 Million Bet On Lifecore Biomedical? Check Out These 4 Stocks Insiders Are Buying ↗
Although US stocks closed mostly lower on Tuesday, there were a few notable insider trades. 
Via Benzinga
News headline image
Lifecore Biomedical Raises Capital for Growth with Existing Stockholder
$5 million PIPE supports near-term capital needs to meet equipment milestones 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.